Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Evaluation of ergocalciferol or cholecalciferol dosing, 1,600 IU daily or 50,000 IU monthly in older adults.

Binkley N, Gemar D, Engelke J, Gangnon R, Ramamurthy R, Krueger D, Drezner MK.

J Clin Endocrinol Metab. 2011 Apr;96(4):981-8. doi: 10.1210/jc.2010-0015.

2.

Vitamin D(3) is more potent than vitamin D(2) in humans.

Heaney RP, Recker RR, Grote J, Horst RL, Armas LA.

J Clin Endocrinol Metab. 2011 Mar;96(3):E447-52. doi: 10.1210/jc.2010-2230.

PMID:
21177785
3.

Fortification of orange juice with vitamin D(2) or vitamin D(3) is as effective as an oral supplement in maintaining vitamin D status in adults.

Biancuzzo RM, Young A, Bibuld D, Cai MH, Winter MR, Klein EK, Ameri A, Reitz R, Salameh W, Chen TC, Holick MF.

Am J Clin Nutr. 2010 Jun;91(6):1621-6. doi: 10.3945/ajcn.2009.27972.

4.

CONSORT 2010 Statement: Updated guidelines for reporting parallel group randomised trials.

Schulz KF, Altman DG, Moher D; CONSORT Group..

J Clin Epidemiol. 2010 Aug;63(8):834-40. doi: 10.1016/j.jclinepi.2010.02.005. No abstract available.

5.

Serum 25-hydroxyvitamin D levels in vitamin D-insufficient hip fracture patients after supplementation with ergocalciferol and cholecalciferol.

Glendenning P, Chew GT, Seymour HM, Gillett MJ, Goldswain PR, Inderjeeth CA, Vasikaran SD, Taranto M, Musk AA, Fraser WD.

Bone. 2009 Nov;45(5):870-5. doi: 10.1016/j.bone.2009.07.015.

PMID:
19631774
6.

The tolerability and biochemical effects of high-dose bolus vitamin D2 and D3 supplementation in patients with vitamin D insufficiency.

Leventis P, Kiely PD.

Scand J Rheumatol. 2009 Mar-Apr;38(2):149-53. doi: 10.1080/03009740802419081.

PMID:
18991184
7.

Pharmacokinetics of vitamin D toxicity.

Jones G.

Am J Clin Nutr. 2008 Aug;88(2):582S-586S. Review.

8.

Short and long-term variations in serum calciotropic hormones after a single very large dose of ergocalciferol (vitamin D2) or cholecalciferol (vitamin D3) in the elderly.

Romagnoli E, Mascia ML, Cipriani C, Fassino V, Mazzei F, D'Erasmo E, Carnevale V, Scillitani A, Minisola S.

J Clin Endocrinol Metab. 2008 Aug;93(8):3015-20. doi: 10.1210/jc.2008-0350.

PMID:
18492750
9.

Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D.

Holick MF, Biancuzzo RM, Chen TC, Klein EK, Young A, Bibuld D, Reitz R, Salameh W, Ameri A, Tannenbaum AD.

J Clin Endocrinol Metab. 2008 Mar;93(3):677-81.

10.
11.

The case against ergocalciferol (vitamin D2) as a vitamin supplement.

Houghton LA, Vieth R.

Am J Clin Nutr. 2006 Oct;84(4):694-7.

12.

Resurrection of vitamin D deficiency and rickets.

Holick MF.

J Clin Invest. 2006 Aug;116(8):2062-72. Review.

13.

Vitamin D2 is much less effective than vitamin D3 in humans.

Armas LA, Hollis BW, Heaney RP.

J Clin Endocrinol Metab. 2004 Nov;89(11):5387-91.

PMID:
15531486
14.

Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase.

Cheng JB, Levine MA, Bell NH, Mangelsdorf DJ, Russell DW.

Proc Natl Acad Sci U S A. 2004 May 18;101(20):7711-5.

15.

Measuring inconsistency in meta-analyses.

Higgins JP, Thompson SG, Deeks JJ, Altman DG.

BMJ. 2003 Sep 6;327(7414):557-60. Review. No abstract available.

16.

De-orphanization of cytochrome P450 2R1: a microsomal vitamin D 25-hydroxilase.

Cheng JB, Motola DL, Mangelsdorf DJ, Russell DW.

J Biol Chem. 2003 Sep 26;278(39):38084-93.

17.

Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses.

Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF.

Lancet. 1999 Nov 27;354(9193):1896-900. Review.

PMID:
10584742
18.

Evidence that vitamin D3 increases serum 25-hydroxyvitamin D more efficiently than does vitamin D2.

Trang HM, Cole DE, Rubin LA, Pierratos A, Siu S, Vieth R.

Am J Clin Nutr. 1998 Oct;68(4):854-8.

PMID:
9771862
19.

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ.

Control Clin Trials. 1996 Feb;17(1):1-12.

PMID:
8721797
Items per page

Supplemental Content

Support Center